The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
Clinical trial NCT05922995 · TERMINATED
Trial details
- NCT number
- NCT05922995
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-30
- Primary completion
- 2023-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.